OVIT (OncoVista Innovative Therapies) 5-Year RORE % : 0.00% (As of Sep. 2015)


What is OncoVista Innovative Therapies 5-Year RORE %?

OncoVista Innovative Therapies OVIT 5-Year RORE % is 0.00 as of Sep. 2015.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. OncoVista Innovative Therapies's 5-Year RORE % for the quarter that ended in Sep. 2015 was 0.00%.

The industry rank for OncoVista Innovative Therapies's 5-Year RORE % or its related term are showing as below:

OVIT's 5-Year RORE % is not ranked *
in the Biotechnology industry.
Industry Median: -10.67
* Ranked among companies with meaningful 5-Year RORE % only.

OncoVista Innovative Therapies  (OTCPK:OVIT) 5-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.

OncoVista Innovative Therapies 5-Year RORE % Related Terms

OncoVista Innovative Therapies 5-Year RORE % Historical Data

* Premium members only.

The historical data trend for OncoVista Innovative Therapies's 5-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoVista Innovative Therapies 5-Year RORE % Chart

OncoVista Innovative Therapies Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
5-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OncoVista Innovative Therapies Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
5-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OVIT vs RSPI, HSTC, CAPS: 5-Year RORE % Comparison

For the Biotechnology subindustry, OncoVista Innovative Therapies's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoVista Innovative Therapies 5-Year RORE % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoVista Innovative Therapies's 5-Year RORE % distribution charts can be found below:

* The bar in red indicates where OncoVista Innovative Therapies's 5-Year RORE % falls into.


OncoVista Innovative Therapies 5-Year RORE % Calculation

OncoVista Innovative Therapies's 5-Year RORE % for the quarter that ended in Sep. 2015 is calculated as:

5-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 5-year -Cumulative Dividends per Share for 5-year )
=( -0.14--0.1 )/( -0.46-0 )
=-0.04/-0.46
=8.70 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Sep. 2015 and 5-year before.

Frequently Asked Questions Learn more about 5-Year RORE % →
What does a 5-Year RORE % of 0.00 mean?
OncoVista Innovative Therapies (OVIT) has a 5-Year RORE % of 0.00 as of Sep. 2015. 5-Year RORE % shows how much a company earns by reinvesting its retained earnings in 5-year. View historical data on OncoVista Innovative Therapies and its competitors.
Is OncoVista Innovative Therapies' 5-Year RORE % too high?
OncoVista Innovative Therapies' current 5-Year RORE % is 0.00.
How does OncoVista Innovative Therapies' 5-Year RORE % compare to RSPI and HSTC?
OncoVista Innovative Therapies' 5-Year RORE % of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year RORE % for a Biotechnology company?
A good 5-Year RORE % depends on the Biotechnology industry context. However, 5-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year RORE % mean?
A high 5-Year RORE % can signal that a stock is expensive relative to its fundamentals. 5-Year RORE % shows how much a company earns by reinvesting its retained earnings in 5-year. View historical data on OncoVista Innovative Therapies and its competitors. OncoVista Innovative Therapies's current 5-Year RORE % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoVista Innovative Therapies stock overvalued right now?
OncoVista Innovative Therapies (OVIT) has a current 5-Year RORE % of 0.00. The current 5-Year RORE % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year RORE % calculated?
5-Year RORE % is calculated from a company's financial statements. For OncoVista Innovative Therapies (OVIT), the current 5-Year RORE % is 0.00 as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoVista Innovative Therapies Business Description

Address 14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245
OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.